<DOC>
	<DOC>NCT00989066</DOC>
	<brief_summary>To evaluate the performance and long-term clinical outcomes of the Xience V everolimus-eluting coronary stent system (EECSS) in the treatment of minimally selective, high risk patients in the real-world clinical practice.</brief_summary>
	<brief_title>Brazil Xience V Everolimus-Eluting Coronary Stent System "Real-World" Outcomes Registry</brief_title>
	<detailed_description>Prospective, multicenter, non-randomized, post-marketing web-based registry.Patients all comers assigned for percutaneous coronary intervention (PCI) who present with at least one angiographically documented coronary artery lesion suitable for percutaneous treatment with implantation of Xience V EECSS only can be included on this Registry.</detailed_description>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<criteria>Patients &gt;18 years of age; clinical indication for elective or emergency PCI with stent implantation of at least one angiographically documented coronary artery lesion; agreement to undergo ALL study protocol followups Diseased coronary vessel(s) with the presence of at least one obstruction &gt;50% diameter stenosis by visual estimation in a major epicardial vessel or a major branch (â‰¥2.50mm), with anatomy suitable for percutaneous treatment with implantation of the Xience V EECSS Known illness with life expectancy &lt;24 months; impossibility to comply with all protocol followups Coronary anatomy unsuitable for percutaneous treatment with implantation of the Xience V EECSS</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>Xience V</keyword>
	<keyword>stent</keyword>
	<keyword>coronary disease</keyword>
</DOC>